GB0007934D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0007934D0
GB0007934D0 GBGB0007934.3A GB0007934A GB0007934D0 GB 0007934 D0 GB0007934 D0 GB 0007934D0 GB 0007934 A GB0007934 A GB 0007934A GB 0007934 D0 GB0007934 D0 GB 0007934D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0007934.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Priority to GBGB0007934.3A priority Critical patent/GB0007934D0/en
Publication of GB0007934D0 publication Critical patent/GB0007934D0/en
Priority to AU2001244355A priority patent/AU2001244355A1/en
Priority to PCT/GB2001/001479 priority patent/WO2001074786A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
GBGB0007934.3A 2000-03-31 2000-03-31 Chemical compounds Ceased GB0007934D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0007934.3A GB0007934D0 (en) 2000-03-31 2000-03-31 Chemical compounds
AU2001244355A AU2001244355A1 (en) 2000-03-31 2001-03-30 Heterobiarylsulphonamides and their use as pde 7 inhibitors
PCT/GB2001/001479 WO2001074786A1 (en) 2000-03-31 2001-03-30 Heterobiarylsulphonamides and their use as pde 7 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0007934.3A GB0007934D0 (en) 2000-03-31 2000-03-31 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0007934D0 true GB0007934D0 (en) 2000-05-17

Family

ID=9888912

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0007934.3A Ceased GB0007934D0 (en) 2000-03-31 2000-03-31 Chemical compounds

Country Status (3)

Country Link
AU (1) AU2001244355A1 (en)
GB (1) GB0007934D0 (en)
WO (1) WO2001074786A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE443518T1 (en) 2001-07-27 2009-10-15 Curis Inc PROVIDERS OF HEDGEHOG SIGNAL PATHS, COMPOSITIONS AND RELEVANT USES
JP4637481B2 (en) * 2001-10-19 2011-02-23 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 2-phenylbenzimidazole and imidazo- [4,5] -pyridine as CDS1 / CHK2 inhibitors and adjuvants for chemotherapy or radiotherapy in cancer treatment
JPWO2003064389A1 (en) * 2002-01-31 2005-05-26 小野薬品工業株式会社 Nitrogen-containing bicyclic compound and drug containing the compound as an active ingredient
EP1988397B8 (en) 2002-12-19 2012-02-15 The Scripps Research Institute Compositions and uses for stabilising transthyretin and inhibiting transthyretin misfolding
ATE363905T1 (en) 2003-04-17 2007-06-15 Janssen Pharmaceutica Nv 2-PHENYL-BENZIMIDAZOLE AND 2-PHENYL-IMIDAZO-4,5)-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER
JP2006219374A (en) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Imidazotriazinone derivative having pde 7 inhibition
JP2006219373A (en) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pyridinylpyrazolopyrimidinone derivative having pde 7 inhibition
EP1694671A2 (en) 2003-12-04 2006-08-30 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
DE102004010194A1 (en) * 2004-03-02 2005-10-13 Aventis Pharma Deutschland Gmbh 4-Benzimidazol-2-yl-pyridazin-3-one derivatives, their preparation and use in medicaments
DE102004010207A1 (en) 2004-03-02 2005-09-15 Aventis Pharma S.A. New 4-benzimidazolyl-3(2H)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
WO2005112913A1 (en) 2004-05-20 2005-12-01 The Scripps Research Institute Transthyretin stabilization
DK2433943T3 (en) 2004-07-01 2013-12-16 Daiichi Sankyo Co Ltd Intermediates for thienopyrazole derivatives with PDE7 inhibitory activity
AU2006261993B2 (en) * 2005-06-22 2011-11-17 Plexxikon, Inc. Pyrrolo (2, 3-B) pyridine derivatives as protein kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
MX2009010450A (en) 2007-03-27 2009-11-23 Omeros Corp The use of pde7 inhibitors for the treatment of movement disorders.
US8637528B2 (en) 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
WO2009012283A1 (en) 2007-07-17 2009-01-22 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
CN110269838A (en) 2009-04-03 2019-09-24 豪夫迈罗氏公司 Propane -1- sulfonic acid { 3- [5- (the chloro- phenyl of 4-) -1H- pyrrolo- [2,3-b] pyridine -3- carbonyl] -2,4- difluorophenyl }-amide compositions and application thereof
MX2012005284A (en) 2009-11-06 2012-06-28 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor.
WO2012035039A1 (en) 2010-09-15 2012-03-22 F. Hoffmann-La Roche Ag Azabenzothiazole compounds, compositions and methods of use
WO2012064667A2 (en) 2010-11-08 2012-05-18 Omeros Corporation Treatment of addiction and impulse-control disorders using pde7 inhibitors
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
AU2012214762B2 (en) 2011-02-07 2015-08-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
TWI558702B (en) 2011-02-21 2016-11-21 普雷辛肯公司 Solid forms of a pharmaceutically active substance
MX2014003043A (en) 2011-09-16 2015-02-05 Pfizer Solid forms of a transthyretin dissociation inhibitor.
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2024038090A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503756A (en) * 1996-11-06 2001-03-21 ダーウィン・ディスカバリー・リミテッド Quinolines and their therapeutic use
WO1999062905A1 (en) * 1998-06-03 1999-12-09 Almirall Prodesfarma, S.A. 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
AU2001244355A1 (en) 2001-10-15
WO2001074786A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
EG26979A (en) Chemical compounds
GB0004890D0 (en) Chemical compounds
AU4699701A (en) Chemical compounds
GB0004886D0 (en) Chemical compounds
GB0002032D0 (en) Chemical compounds
GB0003224D0 (en) Chemical compounds
AU9572301A (en) Chemical compounds
GB0007934D0 (en) Chemical compounds
GB0005642D0 (en) Chemical compounds
AU7993801A (en) Chemical compounds
GB0002034D0 (en) Chemical compounds
GB0007657D0 (en) Chemical compounds
GB0002033D0 (en) Chemical compounds
GB0001346D0 (en) Chemical compounds
GB0000626D0 (en) Chemical compounds
GB0004686D0 (en) Chemical compounds
GB0001348D0 (en) Chemical compounds
GB0002040D0 (en) Chemical compounds
GB0002036D0 (en) Chemical compounds
GB0007245D0 (en) Chemical compounds
GB0002031D0 (en) Chemical compounds
GB0002029D0 (en) Chemical compounds
GB0002041D0 (en) Chemical compounds
GB0008626D0 (en) Chemical compounds
GB0006981D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)